VRXAW Veraxa Biotech AG - Post de-SPAC: institutional ownership and insider trading
28 funds reported holding $1.01M of Veraxa Biotech AG - Post de-SPAC in their latest 13F filings; in Q2 2026 funds net bought $964K, with 27 new positions and 0 funds selling out; over the last 12 months insiders bought $115K and sold $0 on the open market.
Famous investors holding VRXAW
- Izzy Englander (Millennium Management): $22.1K, 0.0% of the portfolio
Largest institutional holders of VRXAW
- CSS LLC/IL — $177K
- LMR Partners LLP — $120K
- Magnetar Financial LLC — $116K
- ARISTEIA CAPITAL, L.L.C. — $116K
- Alberta Investment Management Corp — $96.5K
- AQR Arbitrage LLC — $72.6K
- Clear Street Group Inc. — $53.5K
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $43.8K
- BNP PARIBAS FINANCIAL MARKETS — $27.9K
- MILLENNIUM MANAGEMENT LLC — $22.1K
Recent VRXAW insider trades
- Oct 20, 2026: Ziegler Christoph Samuel bought 30,000 shares ($32.7K)
- Aug 27, 2026: Baumann Oliver Rolf bought 50,000 shares ($75.0K)
- Aug 27, 2026: Antz Christoph Rudiger bought 5,000 shares ($7.65K)
5%+ owners
- Deck David Lukas: 18.0% (Schedule 13D, filed Jun 16, 2026)
- Xlife Sciences AG: 16.3% (Schedule 13D, filed Jun 15, 2026)
- European Molecular Biology Laboratory: 16.2% (Schedule 13D, filed Jun 16, 2026)
- Schoeni Gilbert Edgar: 15.9% (Schedule 13D, filed Jun 15, 2026)